CTOs on the Move

Elcelyx Therapeutics

www.elcelyx.com

 
lcelyx was founded in 2010 with venture capital backing based on Gut Sensory Modulation (GSM) technology. Elcelyx`s proprietary, first-in-class Gut Sensory Modulators are delivered directly to the lower gut where they act on molecular targets to elicit physiological and pharmacological effects. The Elcelyx proprietary product candidate, NewMet for Type 2 diabetes is entering Phase 2b development and is a blockbuster opportunity designed to address the unmet needs in the oral anti-diabetic market. Elcelyx is led by an experienced management team and Board of Directors with track records of success in drug development and commercialization. Premier investors along with seasoned scientists and clinicians ...
  • Number of Employees: 0-25
  • Annual Revenue: $0-1 Million
  • www.elcelyx.com
  • 11995 El Camino Real Suite 305
    San Diego, CA USA 92130-2567
  • Phone: 858.876.1814

Executives

Name Title Contact Details

Funding

Elcelyx Therapeutics raised $40M on 10/01/2015

Similar Companies

IPS Research Company

IPS Research Company is one of the leading providers in Healthcare, Pharmaceuticals, and Biotech. It is based in Oklahoma City, OK. To find more information about IPS Research Company, please visit www.ipsresearch.com

Neurotrope Inc

Neurotrope was formed in October 2012 to develop and market two product platforms, including a non-invasive diagnostic test for Alzheimer's Disease and a drug candidate called bryostatin for the treatment of Alzheimer's Disease, both of which are in the clinical testing stage.  Neurotrope was formed for the primary purpose of commercializing certain technologies that were initially developed by Blanchette Rockefeller Neurosciences Institute ("BRNI") and its affiliates, for therapeutic or diagnostic applications for Alzheimer's Disease or other cognitive dysfunctions.  These technologies have been under development since 1999 and have been financed through significant funding from a variety of non-investor sources. The Company expects that its first product, the diagnostic test for Alzheimer's Disease, will finish the testing phase of its development in 2015, whereupon the Company will evaluate the feasibility of its commercialization.  In addition to bryostatin and the diagnostic test for Alzheimer's Disease, the Company intends to pursue development of two other technology platforms developed by and licensed from BRNI: the first, a platform for transporting drugs into the brain through the "blood-brain-barrier," and the second, a group of drugs for enhancing cognition, mood and alertness for neuropsychiatric conditions.

Tethys Bioscience

Tethys Bioscience is a personalized predictive medicine company developing novel tests which address the growing global healthcare challenge of chronic diseases such as diabetes.

Integra ServiceConnect

Integra ServiceConnect is a non-clinical healthcare service company that connects people to service that improves their health. Specializing in community-based non-clinical support for individuals with healthcare and related social service needs, the Owings Mills, Md.-based company helps health plans, health systems and government organizations find, engage and connect underserved members to care that can preserve and improve their health. Integra has been providing community-based services for individuals with complex healthcare needs for more than two decades.

Harlan County Health System

Harlan County Health System is a Alma, NE-based company in the Healthcare, Pharmaceuticals, and Biotech sector.